Disclosure Of First-Time Adoption [Text Block]

Hyloris Pharmaceuticals SA - Filing #3166293

Concept	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	54,805 EUR	476,000 EUR	—	—	48,056 EUR	—	3,827 EUR	103,693 EUR	2,391 EUR	—	129,000 EUR	—	—	—	43,226 EUR	129,000 EUR	3,827 EUR	—	476,000 EUR	103,693 EUR	1,814 EUR	—	—	59,059 EUR	—	- EUR	493,000 EUR	23,982 EUR	10,188 EUR	36,081 EUR	1,329 EUR	89,000 EUR
Comprehensive income	—	—	- EUR	- EUR	—	- EUR	—	—	—	- EUR	—	11,579 EUR	11,579 EUR	7,145 EUR	—	—	—	7,145 EUR	—	—	—	- EUR	- EUR	—	- EUR	—	—	—	—	—	—	—
Profit (loss)	—	—	—	—	—	—	—	—	—	—	—	11,579 EUR	—	7,145 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—